Iambic Therapeutics, Inc. announces its financial results for Q3 2026, reflecting key metrics that may influence future strategies in the biological products sector.
| Name | Iambic Therapeutics, Inc. |
|---|---|
| CIK | 0001997038 |
| Tickers | IAM |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 843364168 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (626) 592-2520 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Iambic Therapeutics, Inc. announces its financial results for Q3 2026, reflecting key metrics that may influence future strategies in the biological products sector.
Qatar Investment Authority has acquired a 5.8% stake in Iambic Therapeutics, signaling investor confidence in the biological products sector.
Iambic Therapeutics CFO Michael Secora acquires 61,342 shares in a recent transaction, reflecting the company's ongoing activities in the biological products sector.
Iambic Therapeutics' Chairperson William H. Rastetter reports significant stock transactions, indicating strategic moves within the company.
Iambic Therapeutics CFO Michael Secora reports significant stock transactions, highlighting the company's strategic moves in the biotechnology sector.
Iambic Therapeutics, Inc. has filed an amended registration statement for its public offering, reflecting its progress in the biological products sector.
49 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 10-Q | 10-Q | 0001193125-26-468537 | 001-43509 | 261574776 | 34 | 10942843 | 1 | 1 | |
| 2026-11-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-462184 | 001-43509 | 261555583 | 34 | 559945 | 1 | 1 |
| 2026-11-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001441449-26-000012 | 005-96006 | 261534430 | 34 | 6784 | |||
| 2026-10-19 | 4 | PRIMARY DOCUMENT | 0001958125-26-000011 | 30006 | ||||||
| 2026-10-19 | 4 | xslF345X06/form4-10192026_111012.xml | 0002154030-26-000007 | 21759 | ||||||
| 2026-10-19 | 4 | xslF345X06/form4-10192026_111033.xml | 0001855980-26-000009 | 7175 | ||||||
| 2026-10-19 | 4 | xslF345X06/form4-10192026_111025.xml | 0001205903-26-000013 | 18739 | ||||||
| 2026-10-19 | 4 | xslF345X06/form4-10192026_111032.xml | 0002151678-26-000007 | 19976 | ||||||
| 2026-10-16 | 8-K | 8-K | 5.03,7.01,9.01 | 0001193125-26-424242 | 001-43509 | 261466850 | 34 | 435404 | ||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081039.xml | 0001252524-26-000005 | 5467 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081020.xml | 0002154030-26-000005 | 5466 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081043.xml | 0001323304-26-000010 | 5439 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081055.xml | 0001377202-26-000012 | 5460 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081001.xml | 0001205903-26-000011 | 5508 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081024.xml | 0002151678-26-000005 | 5450 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081020.xml | 0001855980-26-000007 | 7385 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081057.xml | 0002155824-26-000005 | 7378 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081058.xml | 0001864141-26-000007 | 7337 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081041.xml | 0002156015-26-000005 | 7388 | ||||||
| 2026-10-16 | 4 | xslF345X06/form4-10162026_081045.xml | 0002034921-26-000007 | 7386 | ||||||
| 2026-10-15 | 424B4 | 424B4 | 0001193125-26-422865 | 333-299057 | 261463096 | 33 | 46467158 | |||
| 2026-10-15 | S-8 | S-8 | 0001193125-26-421986 | 333-299460 | 261461000 | 33 | 372896 | 1 | 1 | |
| 2026-10-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003244 | 333-299057 | 261461201 | 33 | 1755 | ||
| 2026-10-14 | 3 | PRIMARY DOCUMENT | 0001958125-26-000010 | 19285 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101037.xml | 0001252524-26-000003 | 7224 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101050.xml | 0002154030-26-000003 | 16495 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101008.xml | 0001323304-26-000008 | 8505 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101007.xml | 0001377202-26-000010 | 8503 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101012.xml | 0001205903-26-000009 | 16071 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101032.xml | 0002151678-26-000003 | 14034 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101045.xml | 0001781290-26-000003 | 8526 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101057.xml | 0001855980-26-000005 | 12365 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101006.xml | 0002155824-26-000003 | 10709 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101019.xml | 0001864141-26-000005 | 10674 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101058.xml | 0002156015-26-000003 | 15798 | ||||||
| 2026-10-14 | 3 | xslF345X06/form3-10142026_101008.xml | 0002034921-26-000005 | 14756 | ||||||
| 2026-10-14 | CERT | 8A_Cert_IAM_1997038.pdf | 0001354457-26-000988 | 001-43509 | 261459015 | 34 | 181061 | |||
| 2026-10-13 | 8-A12B | 8-A12B | 0001193125-26-420387 | 001-43509 | 261456836 | 34 | 30757 | |||
| 2026-10-08 | S-1/A | S-1/A | 0001193125-26-417416 | 333-299057 | 261448293 | 33 | 48556650 | 1 | 1 | |
| 2026-09-21 | S-1 | S-1 | 0001193125-26-396704 | 333-299057 | 261394235 | 33 | 57188935 | 1 | 1 | |
| 2026-09-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001997038-26-000002 | 021-596810 | 261367363 | 33 | 16169 | ||
| 2026-08-28 | DRS/A | filename1.htm | 0001193125-26-374173 | 377-09598 | 261339224 | 33 | 50109785 | |||
| 2026-07-24 | DRS | filename1.htm | 0001193125-26-315779 | 377-09598 | 261201038 | 33 | 62609555 | |||
| 2026-04-08 | D | xslFormDX01/primary_doc.xml | 06b | 0001997038-26-000001 | 021-579622 | 26849026 | 33 | 15239 | ||
| 2025-11-21 | D | xslFormDX01/primary_doc.xml | 06b | 0001997038-25-000002 | 021-564708 | 251505753 | 33 | 15242 | ||
| 2024-06-06 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001997038-24-000003 | 021-511607 | 241024335 | 33 | 12804 | ||
| 2024-05-07 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001997038-24-000002 | 021-511607 | 24922223 | 33 | 12801 | ||
| 2024-04-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001997038-24-000001 | 021-511607 | 24875673 | 33 | 12707 | ||
| 2023-10-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001997038-23-000001 | 021-494624 | 231323304 | 33 | 12673 |
One latest value per concept from companyfacts (104 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 48.93M | 2026-11-16 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 13,411.98 | 2026-10-13 | S-8 | 2026-10-15 | 0001193125-26-421986 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 13,411.98 | 2026-10-13 | S-8 | 2026-10-15 | 0001193125-26-421986 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 154.16M | 2026-10-13 | S-8 | 2026-10-15 | 0001193125-26-421986 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-13 | S-8 | 2026-10-15 | 0001193125-26-421986 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 13,810 | 2026-10-08 | S-1/A | 2026-10-08 | 0001193125-26-417416 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 4.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 733,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 4.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 38,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 14.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 36.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | Assets | Assets | USD | 332.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 315.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 269,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 252.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 252.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 252.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 72.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 33.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 238.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 4.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 4.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -88.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 96.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination | USD | 99.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 8.62M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 76.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 4.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 44.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 51.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -20.37 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -20.37 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 5.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 13.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 76,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 16.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -88.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 54.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 603,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | 75.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 531,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 5.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | Liabilities | Liabilities | USD | 207.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 332.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 74.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | LiabilitiesFairValueAdjustment | Liabilities, Fair Value Adjustment | USD | -10.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 120.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -5.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -43.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -88.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -5.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 107.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -83.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 743,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 4.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 2.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 14,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 5.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 9,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -52,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 5.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | PreferredStockDividendsPerShareDeclared | Preferred Stock, Dividends Per Share, Declared | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 8.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 66.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 2.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -88.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 14.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 9.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 50.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 91.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 562,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -283.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 24.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 3.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 2.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 7.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 3.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -269.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 394.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 395.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 181.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 28.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 28.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | UnbilledReceivablesCurrent | Unbilled Receivables, Current | USD | 4.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 4.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-19 | 0001193125-26-468537 |